Literature DB >> 27634620

Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.

Mais Al-Kawaz1, Elizabeth Monohan1, Eric Morris1, Jai S Perumal1,2, Nancy Nealon1,2, Timothy Vartanian1,2, Susan A Gauthier1,2.   

Abstract

BACKGROUND: African Americans with multiple sclerosis (AAwMS) have different disease phenotypes when compared to Caucasians Americans with MS (CAwMS). The pathologic basis of this difference in disease presentation is unknown.
METHODS: Fifty-Four AAwMS and 54 CAwMS were appropriately matched for age, gender, treatment duration, and disease duration. FreeSurfer was used to segment brain white matter and gray matter from T1 images and compute thalamic volume. Regional cortical thickness was calculated using QDEC.
RESULTS: The 2 matched cohorts differed in disability, with AAwMS demonstrating significantly higher EDSS scores (2.3±2.2 vs. 1.3±1.5, P < .009), yet the 2 populations had similar T2 hyperintense lesion volumes (P = .35). AAwMS had a significantly lower total global cortical thickness when compared to CAwMS (P = .03). Controlling for EDSS, AAwMS showed multiple cortical regions to be significantly thinner than CAwMS; these included areas within the temporal, parietal and occipital lobes, as well as the precentral and postcentral gyrus. Middletemporal cortex was most affected in AAwMS in the left hemisphere (P = .009), while the superiortemporal cortex was most affected in the right hemisphere (P = .0001). In contrast, thalamic volume was significantly reduced in CAwMS when compared to AAwMS (P = .01). In both groups, worse disability was associated with lower total thalamic volume percentage.
CONCLUSION: AAwMS and CAwMS patients differ with regard to global and regional cortical thickness and thalamic volume. This diverging pattern of gray matter volumetrics among otherwise matched patients suggests that racial-specific disease differences may exist.
Copyright © 2016 by the American Society of Neuroimaging.

Entities:  

Keywords:  African American (AA); Caucasian (CA); Multiple sclerosis; cortical thickness; gray matter; thalamic volume

Mesh:

Year:  2016        PMID: 27634620     DOI: 10.1111/jon.12393

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  7 in total

1.  An MRI evaluation of grey matter damage in African Americans with MS.

Authors:  Maria Petracca; Wafaa Zaaraoui; Sirio Cocozza; Roxana Vancea; Jonathan Howard; Monika M Heinig; Lazar Fleysher; Niels Oesingmann; Jean-Philippe Ranjeva; Matilde Inglese
Journal:  Mult Scler Relat Disord       Date:  2018-07-12       Impact factor: 4.339

2.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

Review 3.  Clinical Characteristics of Multiple Sclerosis in African-Americans.

Authors:  Veronica P Cipriani; Sara Klein
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

4.  Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.

Authors:  Renxin Chu; Gloria Kim; Shahamat Tauhid; Fariha Khalid; Brian C Healy; Rohit Bakshi
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

5.  A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.

Authors:  Yuri Nakamura; Laura Gaetano; Takuya Matsushita; Altermatt Anna; Till Sprenger; Ernst-Wilhelm Radue; Jens Wuerfel; Lorena Bauer; Michael Amann; Koji Shinoda; Noriko Isobe; Ryo Yamasaki; Takahiko Saida; Ludwig Kappos; Jun-Ichi Kira
Journal:  J Neuroinflammation       Date:  2018-09-05       Impact factor: 8.322

6.  Black African and Latino/a identity correlates with increased plasmablasts in MS.

Authors:  Kiel M Telesford; Ulrike W Kaunzner; Jai Perumal; Susan A Gauthier; Xian Wu; Ivan Diaz; Mason Kruse-Hoyer; Casey Engel; Melanie Marcille; Timothy Vartanian
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-10-31

7.  Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).

Authors:  Annette F Okai; Lilyana Amezcua; Regina R Berkovich; Angel R Chinea; Keith R Edwards; Brian Steingo; Aljoeson Walker; Alan K Jacobs; Nadia Daizadeh; Mitzi J Williams
Journal:  Neurol Ther       Date:  2019-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.